Drug Trial Radar · NCT00567255
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects
Last checked: Nov 19, 2026Latest source record: Nov 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,496
Actual
Start
Dec 2007
Primary completion
Jun 2009
Study completion Jun 2009
Sponsor
- Lead sponsor
- Orexigen Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- Dec 4, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the combination of naltrexone SR and bupropion SR is safe and effective in the treatment of obesity.
Conditions
- Obesity
- Overweight
Interventions
Naltrexone SR 32 mg/bupropion SR 360 mg/dayDrug
PlaceboDrug
Ancillary therapyBehavioral
Ancillary therapy consisting of diet instruction, advice on behavior modification, and exercise counseling
Primary outcomes
What the sponsor says the trial is designed to measure.
- Co-primary: Body Weight- Mean Percent Change From Baseline to Week 28Time frame: Baseline, 28 weeks
- Co-primary: Body Weight- Proportion of Subjects With ≥5% Decrease From Baseline to Week 28Time frame: Baseline, 28 weeks
Locations
36 sites in 1 country. Site status is shown where the registry gives one.
Lovelace Scientific Resources
Phoenix, Arizona
HOPE Research Institute
Phoenix, Arizona
HealthStar Research
Hot Springs, Arkansas
Northern California Research
Carmichael, California
Sierra Medical Research
Fresno, California
Pharmacology Research Institute
Newport Beach, California
Center for Human Nutrition University of Colorado Health Sciences Center
Denver, Colorado
Chase Medical Research, LLC
Waterbury, Connecticut
George Washington University
Washington D.C., District of Columbia
Suncoast Clinical Research
Palm Harbor, Florida
Comprehensive NeuroScience, Inc
Atlanta, Georgia
Clinical Research Atlanta
Stockbridge, Georgia
Northwest Indiana Center for Clinical Research
Valparaiso, Indiana
Trover Center for Clinical Studies
Madisonville, Kentucky
Nutrition and Weight Mangement Center Boston Medical Center
Boston, Massachusetts
Milford Emergency Associates, Inc
Milford, Massachusetts
Summit Research Network, Inc.
Okemos, Michigan
Twin Cities Clinical Research
Brooklyn Center, Minnesota
Mercy Health Research
St Louis, Missouri
Radiant Research, Inc.
St Louis, Missouri
Clinical Research Center of Nevada
Las Vegas, Nevada
Endocrinology & Diabetes Consultants
Dover, New Hampshire
Lovelace Scientific Resources
Albuquerque, New Mexico
Central New York Clinical Research
Manlius, New York
Comprehensive Weight Control Program
New York, New York
Behavioral Medical Research
Staten Island, New York
Metrolina Medical Research
Charlotte, North Carolina
Patient Priority
Cincinnati, Ohio
Wells Institute For Health Awareness
Kettering, Ohio
The Portland Clinic
Portland, Oregon
Geisinger Medical Center
Danville, Pennsylvania
Mountain View Clinical Research
Greer, South Carolina
Palmetto Medical Research
Mt. Pleasant, South Carolina
Clinical Research Associates, Inc.
Nashville, Tennessee
The Cooper Institute
Dallas, Texas
Summit Research Network, Inc.
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.